IP Library › Granted Patent US 12,371,680
Granted Patent B2
US 12,371,680 · App. 18/504,010 · Granted Jul 29, 2025

Terminal deoxynucleotidyl transferase variants and uses thereof

Inventors: Elise Champion (Paris, FR); Jérôme Loc'h (Le Kremlin-Bicêtre, FR); Mikhael Soskine (Franconville, FR); Elodie Sune (Le Kremlin-Bicêtre, FR)
Assignee: DNA Script SAS
C12N9/1264C12Y207/07031
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,371,680
App. No.
18/504,010
Granted
Jul 29, 2025
Kind
B2
Abstract

The present invention is directed to terminal deoxynucleotidyltransferase (TdT) variants that (i) comprise an amino acid sequence that is at least a specified percent identical to an indicated SEQ ID NOs and have at least one substitution at Q455 or at least Q455 plus at least one further substitution at G186, S248, T331, Q390, K394 or H466 (where positions are with respect to SEQ ID NO 1 and functionally equivalent positions in indicated SEQ ID NOs), (ii) are capable of template-free extension of a polynucleotide, and (iii) exhibit enhanced stability or enhanced efficiency in incorporating 3′-0-blocked nucleoside triphosphates into a polynucleotide. The invention is also directed to the use of these TdT variants for synthesizing polynucleotides of any predetermined sequence.

Claims (40)

1. A terminal deoxynucleotidyl transferase (TdT) variant comprising an amino acid sequence at least ninety percent identical to an amino acid sequence selected from SEQ ID NO: 3, 9, 11, or 15, with a G57E substitution with respect to SEQ ID NO: 3, or an amino acid sequence at least ninety percent identical to the amino acid sequence of SEQ ID NO: 27 and having an E at position 57 with respect to SEQ ID NO:3, wherein the TdT variant (i) is capable of synthesizing a nucleic acid fragment without a template and (ii) is capable of incorporating a 3′-O-modified nucleotide onto a nucleic acid fragment.

2. The TdT variant of claim 1 , further comprising one or more of:

(i) a substitution at position K265 with respect to SEQ ID NO: 3;

(ii) a substitution at position H337 with respect to SEQ ID NO: 3;

(iii) a substitution at position W377 with respect to SEQ ID NO: 3;

(iv) a substitution at position A17 with respect to SEQ ID NO: 3;

(v) a substitution at position Q326 with respect to SEQ ID NO: 3; or

(vi) a substitution at position Q261 with respect to SEQ ID NO: 3.

3. The TdT variant of claim 2 , wherein said TdT variant comprises a substitution at position K265 with respect to SEQ ID NO: 3, and wherein said substitution at position K265 is selected from the group consisting of E, T, A and R.

4. The TdT variant of claim 2 , wherein said TdT comprises a substitution at position Q261 with respect to SEQ ID NO: 3, and wherein the substitution at position Q261 is R.

5. The TdT variant of claim 1 , further comprising one or more of:

(i) a substitution at position L52 with respect to SEQ ID NO: 3;

(ii) a substitution at position M63 with respect to SEQ ID NO: 3;

(iii) a substitution at position A108 with respect to SEQ ID NO: 3;

(iv) a substitution at position L131 with respect to SEQ ID NO: 3;

(v) a substitution at position C173 with respect to SEQ ID NO: 3;

(vi) a substitution at position R207 with respect to SEQ ID NO: 3;

(vii) a substitution at position G284 with respect to SEQ ID NO: 3;

(viii) a substitution at position E289 with respect to SEQ ID NO: 3;

(ix) a substitution at position R325 with respect to SEQ ID NO: 3;

(x) a substitution at position E328 with respect to SEQ ID NO: 3; or

(xi) a substitution at position R351 with respect to SEQ ID NO: 3.

6. The TdT variant of claim 1 , further comprising one or more of:

(i) a substitution Q37E with respect to SEQ ID NO: 3;

(ii) a substitution D41R with respect to SEQ ID NO: 3;

(iii) a substitution C59R with respect to SEQ ID NO: 3;

(iv) a substitution L60D with respect to SEQ ID NO: 3;

(v) a substitution S94R with respect to SEQ ID NO: 3;

(vi) a substitution G98E with respect to SEQ ID NO: 3;

(vii) a substitution S119A with respect to SEQ ID NO: 3;

(viii) a substitution S146E with respect to SEQ ID NO: 3;

(ix) a substitution Q149R with respect to SEQ ID NO: 3;

(x) a substitution F193Y with respect to SEQ ID NO: 3;

(xi) a substitution V199M with respect to SEQ ID NO: 3.

7. A method of synthesizing a polynucleotide having a predetermined sequence, the method comprising the steps of:

(a) providing an initiator having a 3′-terminal nucleotide having a free 3′-hydroxyl;

(b) repeating cycles of (i) contacting under elongation conditions the initiator or elongated fragments having free 3′-O-hydroxyls with a 3′-O-blocked nucleoside triphosphate and a TdT variant according to claim 1 , so that the initiator or elongated fragments are elongated by incorporation of a 3′-O-blocked nucleoside triphosphate to form 3′-O-blocked elongated fragments, and (ii) deblocking the elongated fragments to form elongated fragments having free 3′-hydroxyls, until the polynucleotide is formed.

8. A kit for performing a nucleotide incorporation reaction comprising:

(a) a TdT variant of claim 1 ; and

(b) one or more 3′-O-modified nucleotides.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 5, 2023
From: CHAMPION, ELISE; SOSKINE, MIKHAEL; SUNE, ELODIE
To: DNA SCRIPT SAS
Reel/Frame 065766/0920 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 5, 2023
From: LOC'H, JÉRÖME
To: DNA SCRIPT SAS
Reel/Frame 065781/0620 →
Priority Claims (3)
EP 18206298 · Nov 14, 2018 · regional
EP 19305677 · May 28, 2019 · regional
EP 19195662 · Sep 5, 2019 · regional
Continuity (2)
Continuation 17293017
Related Publication 20240093165A1 · Mar 21, 2024
References Cited (45)
US 5436143A · Hyman · 1995 [cited by applicant]
US 5739386A · Holmes · 1998 [cited by applicant]
US 5763594A · Hiatt et al. · 1998 [cited by applicant]
US 5808045A · Hiatt et al. · 1998 [cited by applicant]
US 7057026B2 · Barnes et al. · 2006 [cited by applicant]
US 7544794B1 · Benner · 2009 [cited by applicant]
US 8808988B2 · Zhao et al. · 2014 [cited by applicant]
US 10752887B2 · Champion · 2020 [cited by examiner]
US 10760063B2 · Efcavitch et al. · 2020 [cited by applicant]
US 10774316B2 · Efcavitch et al. · 2020 [cited by applicant]
US 11390858B2 · Tubbs et al. · 2022 [cited by applicant]
US 11859217B2 · Champion et al. · 2024 [cited by applicant]
US 20050037991A1 · Bodepudi et al. · 2005 [cited by applicant]
US 20220112534A1 · Chen et al. · 2022 [cited by applicant]
CA 3024184A1 · 2017 [cited by applicant]
CN 105264085A · 2016 [cited by applicant]
CN 107567501A · 2018 [cited by applicant]
FR 3052462A1 · 2017 [cited by applicant]
WO 9106678A1 · 1991 [cited by applicant]
WO 2004005667A1 · 2004 [cited by applicant]
WO 2015159023A1 · 2015 [cited by applicant]
WO 2016064880A1 · 2016 [cited by applicant]
WO 2017216472A2 · 2017 [cited by applicant]
WO WO2018215803A1 · 2018 [cited by examiner]
WO 2020099451A1 · 2020 [cited by applicant]
Q5EB91_RAT. UnitProtKB/TrEMBL. May 23, 2018. [cited by examiner]
Becker, A. et al. (1967) “The Enzymatic Cleavage of Phosphate Termini from Polynucleotides,” J. Biol. Chem., 242(5):936-950. [cited by applicant]
Benatolila, L.A. et al. (1995). “The Two Isoforms of Mouse Terminal Deoxynucleotidyl Transferase Differ in Both the Ability to Add N Regions and Subcellular Localization,” The EMBO Journal 14(17):4221-4229. [cited by applicant]
Boule, J-B. et al. (1998). “High-Level Expression of Murine Terminal Deoxynucleotidyl Transferase in [cited by applicant]
Cameron, V. et al. (1977). “3′-Phosphatase Activity in T4 Polynucleotide Kinase”, Biochemistry 16(23):5120-5126. [cited by applicant]
Canard, B. et al. (Nov. 21, 1995). “Catalytic Editing Properties of DNA Polymerases” Proc. Natl. Acad. Sci., 92:10859-10863. [cited by applicant]
Canard, B. et al. (Oct. 11, 1994). “DNA Polymerase Fluorescent Substrates with Reversible 3′-Tags” Gene 148(1):1-6. [cited by applicant]
Corpet, F. (Nov. 25, 1988). “Multiple Sequence Alignment with Hierarchical Clustering,” Nucl. Acids Res. 16(22):10881-10890. [cited by applicant]
Delarue, M. et al. (Feb. 1, 2002). “Crystal Structures of a Template-Independent DNA Polymerase: Murine Terminal Deoxynucleolidyltransferase”, The Embo Journal 21(3):427-439. [cited by applicant]
Ferrero, M. et al. (2000). “Chemoenzymalic Transformations in Nucleoside Chemistry” Monatshefte fur Chemie, 131:585-616. [cited by applicant]
Grantham, R. (1974). “Amino Acid Difference Formula to Help Explain Protein Evolution,” Science 185(4154):862-864. [cited by applicant]
Jensen, M.A. et al. (Mar. 27, 2018. e-pub Mar. 13, 2018). “Template-Independent Enzymatic Oligonucleolide Synthesis (TiEOS): Its History, Prospects and Challenges” Biochemistry, 57:1821-1832. [cited by applicant]
Kodumal, S.J. et al. (2004). “Total Synthesis of Long DNA sequences: Synthesis of Acontiguous 32-kb Polyketide Synthase Gene Cluster”, The National Academy of Sciences of the USA, 101(44):15573-15578. [cited by applicant]
Meng, Q. et al. (2006). “Design and Synthesis of a Photocleavable Fluorescent Nucleotide 3′-O-Allyl-dGTP-PC-Bodipy-FL-510 as Reversible Terminator for DNA Sequencing by Synthesis,” J. Org. Chem. 71:3248-3252. [cited by applicant]
Metzker, M.L. et al. (Oct. 11, 1994). “Termination of DNA Synthesis by Novel 3′-Modifieddeoxyribonucleoside 5′-Triphosphates” Nucleic Acids Research, 22(20):4259-4267. [cited by applicant]
Rasolonjatovo, I. et al. (1999). “Development of a New DNA Sequencing Method: 3′-Ester Cleavage Catalyzed by Taq DNA Polymerase”, Nucleosides & Nucleotides 18(4-5):1021-1022. [cited by applicant]
Schmitz, C. et al. (1999. E-pub. Nov. 6, 1999). “Solid-Phase Enzymatic Synthesis of Oligonucleotidest” Organic Lett. 1(11):1729-1731. [cited by applicant]
Stemmer, W.P. et al. (Oct. 16, 1995). “Single-step Assembly of a Gene and Entire Plasmid From Large Numbers of Oligodeoxyribonucleotides” Gene 164:49-53. [cited by applicant]
Taunton-Rigby, A. (1973). “Oligonucleotide Synthesis. III. Enzymically Removable Acyl Protecting Groups” J. Org. Chem. 38(5):977-985. [cited by applicant]
Uemura, A. et al. (1989). “Regioselective Deprotection of 3′,5′-O-acylated Pyrimidine Nucleosides by Lipase and Esterase”, Tetrahedron Lett. 30(29):3819-3820. [cited by applicant]
Cited By (1)
US 12,606,856